Beluister Presentations & Publications Delen Facebook Linkedin Twitter Whatsapp Email Axiomer technology Axiomer RNA editing technology Download link ProQR AX-0810 Investor & Analyst Event - November 2025 pdf, 2.94 MB Download link OTS (de Lang 2025) Leveraging Chemically Modified Single-stranded RNA Editing Oligonucleotides For Therapeutic Applications pdf, 693.28 kB Download link RNA Editing Summit (Platenburg 2025) Axiomer in the CNS pdf, 3.08 MB Download link TIDES US (2025) Beal Axiomer platform pdf, 1.64 MB Download link ASGCT (2025) Platenburg NTCP (abstract 333) pdf, 1.68 MB Download link ASGCT (2025) Platenburg et al., PNPLA3-I148M (abstract 1654) pdf, 1.44 MB Download link ASGCT (2025) Platenburg et al., MECP2 for Rett Syndrome (abstract 1645) pdf, 1.37 MB Download link GRC RNA Editing (2025) Platenburg Exploring ADAR RNA editing therapeutic applications pdf, 2.39 MB Download link ProQR Investor & Analyst Event 2024 Presentation pdf, 17.77 MB Download link OTS (2024) Gerard Platenburg Platenburg 2024 OTS - Oligonucleotide guided editing of NTCP for cholestatic diseases pdf, 1.54 MB Download link RNA Editing Summit (2024) Developing Axiomer RNA Editing Technology Towards Clinical Development pdf, 2.83 MB Externe link ASGCT (2024) Partnership poster, Lilly, Complex Metabolism and Prolonged PK/PD of a GalNAc-Conjugated Editing Oligonucleotide (EON) in Mice Externe link ASGCT (2024) Gerard Platenburg et al., Robust and Durable RNA Editing In Vivo with Axiomer Editing Oligonucleotides in Non Human Primates Externe link Deaminet (2024) Gerard Platenburg, Axiomer an RNA editing technology Externe link RNA Editing Summit (2023) Harnessing chemical modifications to improve ADAR potency and unlock Axiomer broad applicability Interne link DATS (2023) Monica Aguila, Exploring the potential of new RNA editing technologies leveraging ADAR endogenous machinery Interne link TIDES USA (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders Interne link Analyst & Investor Axiomer Technology R&D Event (2023) Interne link GRC (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides to Address Liver Originated Disorders Interne link OPT Congress (2023) Gerard Platenburg, Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs) Interne link TIDES Europe (2022) Gerard Platenburg, Progress on Development of RNA Base Editing Technologies for Precision Medicines Interne link TIDES USA (2022) Gerard Platenburg, Development of RNA Base Editing Technologies for Precision Medicines Download link Axiomer™ Technology Overview pdf, 2.25 MB Interne link JACS (2021) Erin E. Doherty et al., Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position Interne link OTS (2018) Julien Boudet et al., Structure-based computational approach for optimizing oligonucleotides for A-to-I editing Interne link TIDES EU (2018) Antti Aalto, Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes Deel pagina Facebook Linkedin Twitter Whatsapp Email
Download link OTS (de Lang 2025) Leveraging Chemically Modified Single-stranded RNA Editing Oligonucleotides For Therapeutic Applications pdf, 693.28 kB
Download link GRC RNA Editing (2025) Platenburg Exploring ADAR RNA editing therapeutic applications pdf, 2.39 MB
Download link OTS (2024) Gerard Platenburg Platenburg 2024 OTS - Oligonucleotide guided editing of NTCP for cholestatic diseases pdf, 1.54 MB
Download link RNA Editing Summit (2024) Developing Axiomer RNA Editing Technology Towards Clinical Development pdf, 2.83 MB
